Principal, Ernst & Young’s Parthenon Strategy Practice
Mark is a principal in EY’s Parthenon Strategy Practice focusing on Health and Life Sciences. Mark has over 25 years of experience in strategy, market research, acquisition integration, divestiture carve-out, process improvement, regulatory compliance, organizational effectiveness, and change management. Mark has experience in all aspects of life sciences, including pharmaceuticals, biotechnology, medical device, diagnostics, and healthcare distribution. Mark has authored many whitepapers and articles on various aspects of life sciences. Mark is also a frequent speaker at life sciences conferences. Mark is a Board Member and Past President of the Cystic Fibrosis Foundation, Northern California.